<h1>Aredia </h1><p>Aredia, pamidronate disodium (APD), is a bone-resorption inhibitor available in 30-mg or 90-mg vials for
intravenous administration. Each 30-mg and 90-mg vial contains, respectively, 30 mg and 90 mg of
sterile, lyophilized pamidronate disodium and 470 mg and 375 mg of mannitol, USP. The pH of a 1%
solution of pamidronate disodium in distilled water is approximately 8.3. Aredia, a member of the group
of chemical compounds known as bisphosphonates, is an analog of pyrophosphate. Pamidronate disodium
is designated chemically as phosphonic acid (3-amino-1-hydroxypropylidene) bis-, disodium salt,
pentahydrate, (APD)</p>
intravenous administration. Each 30-mg and 90-mg vial contains, respectively, 30 mg and 90 mg of
sterile, lyophilized pamidronate disodium and 470 mg and 375 mg of mannitol, USP. The pH of a 1%
solution of pamidronate disodium in distilled water is approximately 8.3. Aredia, a member of the group
of chemical compounds known as bisphosphonates, is an analog of pyrophosphate. Pamidronate disodium
is designated chemically as phosphonic acid (3-amino-1-hydroxypropylidene) bis-, disodium salt,
pentahydrate, (APD)</p>